A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka factors, proteins ...

By combining advanced cellular reprogramming with AI-driven protein design, the company aims to reverse biological ageing and tackle multiple diseases at once.

Mesenchymal drift may help explain how cells lose stable identity and acquire pro-fibrotic, inflammatory mesenchymal traits ...

Longevity science races to slow ageing, from AI driven drug discovery to cellular rejuvenation, with leaders like David ...

For years, Silicon Valley treated ageing as a background fact of life rather than a technical problem. Wealth from the AI ...